Related references
Note: Only part of the references are listed.Purification of IgG and albumin from human plasma by aqueous two phase system fractionation
Mariangela Vargas et al.
BIOTECHNOLOGY PROGRESS (2012)
Experimental design in chromatography: A tutorial review
D. Brynn Hibbert
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010
Gregory W. Daniel et al.
TRANSFUSION (2012)
Immunoglobulin therapy and thrombosis: coincidence or causation?
Douglass A. Drelich et al.
TRANSFUSION (2012)
Identification of kallikrein and FXIa as impurities in therapeutic immunoglobulins: implications for the safety and control of intravenous blood products
M. Etscheid et al.
VOX SANGUINIS (2012)
Antibody capture by mixed-mode chromatography: A comprehensive study from determinaton of optimal purification conditions to identification of contaminating host cell proteins
Jerome Pezzini et al.
JOURNAL OF CHROMATOGRAPHY A (2011)
A novel core fractionation process of human plasma by expanded bed adsorption chromatography
Allan Lihme et al.
ANALYTICAL BIOCHEMISTRY (2010)
Evidence for the Use of Intravenous Immunoglobulins-A Review of the Literature
Shaye Kivity et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2010)
Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance
M. Radosevich et al.
VOX SANGUINIS (2010)
Case-control study of thromboembolic events associated with IV immunoglobulin
James B. Caress et al.
JOURNAL OF NEUROLOGY (2009)
A virally inactivated functional growth factor preparation from human platelet concentrates
C. -Y. Su et al.
VOX SANGUINIS (2009)
Intravenous Immunoglobulins: Evolution of Commercial IVIG Preparations
John A. Hooper
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)
Quantitative assessment of the kinetics of growth factors release from platelet gel
Chen Y. Su et al.
TRANSFUSION (2008)
A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity
G. Poelsler et al.
VOX SANGUINIS (2008)
Intravenous immunoglobulin:: An update on the clinical use and mechanisms of action
Vir-Singh Negi et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
Adverse Reactions and Pathogen Safety of Intravenous Immunoglobulin
Javier Carbone
CURRENT DRUG SAFETY (2007)
A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state-of-the-art process
W. Teschner et al.
VOX SANGUINIS (2007)
A modified caprylic acid method for manufacturing immunoglobulin G from human plasma with high yield and efficient virus clearance
J Parkkinen et al.
VOX SANGUINIS (2006)
Intravenous immunoglobulin in immunodeficiency states - State of the art
E Toubi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2005)
Intravenous immunoglobulin - Adverse effects and safe administration
H Orbach et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2005)
Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature
D Hefer et al.
ANNALS OF HEMATOLOGY (2004)
Risks associated with the use of intravenous immunoglobulin
LR Pierce et al.
TRANSFUSION MEDICINE REVIEWS (2003)
Properties of a new intravenous immunoglobulin (IGIV-C, 10%) produced by virus inactivation with caprylate and column chromatography
W Lebing et al.
VOX SANGUINIS (2003)
Composition and properties of IVIg preparations that affect tolerability and therapeutic efficacy
G Lemm
NEUROLOGY (2002)
Inactivation of lipid enveloped viruses by octanoic acid treatment of immunoglobulin solution
H Dichtelmüller et al.
BIOLOGICALS (2002)
Reducing the risk of infection from plasma products: specific preventative strategies
T Burnouf et al.
BLOOD REVIEWS (2000)
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
HM Chapel et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2000)
Share Paper
